TAG
SEC
Covaxin has 77.3% efficacy: Phase 3 trials data
Bharat Biotech have announced that the indigenously developed Covid-19 vaccine Covaxin has showed a 77.3 per cent efficacy in its phase 3 trials.
The company...
India on cusp of another home-made vaccine; now in 3rd phase of trials
In the latest development, India is all set to get its second “Made in India” vaccination after Biological E. Limited (BE) on Saturday announced...
BJP takes big leads in Gujarat municipal elections
The BJP has made big gains in early leads in the six municipal corporation elections in Gujarat early this morning.
The ruling BJP is leading...
Look at Moody’s whom media quotes with relish
In this second part of our series where NewsBred shows our mainstream media quoting discredited sources on front page to slam the government for "growing...